20
Participants
Start Date
May 31, 2013
Primary Completion Date
November 30, 2013
Study Completion Date
December 31, 2013
Prevenar13
Immunedeficiency Unit, Karolinska University Hospital, Huddinge, Stockholm
Collaborators (1)
Pfizer
INDUSTRY
Karolinska University Hospital
OTHER